Latest News about CRSP
Recent news which mentions CRSP
   Chardan Capital Maintains Buy Rating for CRISPR Therapeutics: Here's What You Need To Know
   
  June 22, 2022
  Tickers 
   CRSP
  
  
  From Benzinga
 
   Why Bluebird Bio Skyrocketed Today
   
  
  
  June 17, 2022
  From Motley Fool
 
   3 Bargain Stocks You Can Buy Today and Hold Forever
   
  
  
  June 17, 2022
  From Motley Fool
 
   CNBC's Final Trades: Ethereum, Charles Schwab, Clean Energy, Boeing And This Biotech Stock
   
  
  
  June 16, 2022
  From Benzinga
 
   2 Top Biotech Stocks Ready for Bull Runs
   
  
  
  June 15, 2022
  From Motley Fool
 
   93 Biggest Movers From Yesterday
   
  
  
  June 14, 2022
  From Benzinga
 
   Analysts Consider CRISPR Therapeutics' Blood Disorder Trial Data Encouraging, Impressive
   
  
  
  June 13, 2022
  From Benzinga
 
   70 Stocks Moving In Monday's Mid-Day Session
   
  
  
  June 13, 2022
  From Benzinga
 
   2 Hot Stocks to Buy and Hold Until You Retire
   
  
  
  June 12, 2022
  From Motley Fool
 
   7 No-Brainer Biotech Stocks to Add to Your Buy List
   
  
  
  June 09, 2022
  From InvestorPlace
 
   7 Oversold Stocks to Buy Right Now
   
  
  
  June 08, 2022
  From InvestorPlace
 
   2 Top Biotech Stocks to Buy in June
   
  
  
  June 08, 2022
  From Motley Fool
 
   2 Green Flags for Vertex Pharmaceuticals' Future
   
  
  
  June 03, 2022
  From Motley Fool
 
   Have $2,000? 2 Market Crash-Ready Stocks to Buy
   
  
  
  May 22, 2022
  From Motley Fool
 
   How to Buy Stocks in a Recession
   
  
  
  May 16, 2022
  From InvestorPlace
 
   5 Cathie Wood Stocks to Buy Now
   
  
  
  May 16, 2022
  From InvestorPlace
 From Motley Fool
 
   Why Editas Medicine's Shares Fell 28.9% This Week
   
  
  
  May 13, 2022
  From Motley Fool
 From Motley Fool
 From Motley Fool
 
   Why Cathie Wood's Flagship ETF Slumped This Week
   
  
  
  May 12, 2022
  From Motley Fool
 From Benzinga
 From Motley Fool
 
   2 Biotech Stocks to Buy and Hold for 10 Years
   
  
  
  April 30, 2022
  From Motley Fool
 From Benzinga
 
   What 4 Analyst Ratings Have To Say About CRISPR Therapeutics
   
  April 28, 2022
  Tickers 
   CRSP
  
  
  From Benzinga
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.